When should early-stage companies should begin thinking about implementing quality systems? Here’s why the answer is “yesterday.”
Welcome to our effort to facilitate discussion and experimentation with best practices and novel tools as oure industry looks to accelerate product development, manufacturing scale-up, and technology transfer.
We are excited to announce that Lung Therapeutics has selected to implement QbDVision to provide critical transparency between R&D, process development, manufacturing, and commercialization.
Welcome Jean Marie Schiraldi as our new Customer Success Manager. Joining us from Veeva, she comes with a deep background in leading-edge software applications for the life sciences industry.
IFPAC 2020 was the last in-person conference we attended before the COVID-19 pandemic reshaped our industry’s major global conferences. We’re excited to be back!
If software releases were like your favorite TV series, get ready to start binge-watching Season 5 of QbDVision!
Since its inception, QbDVision has integrated risk assessment functionality into its core. Explore our platform’s latest risk ranking functionality.
Companies developing and manufacturing biologics are heavily focused on product quality metrics to ensure patient safety and efficacy. They are equally focused on the optimization …
As your team cycles through the development process, there is one constant: change underpinned by learning from each phase. Here’s the digital way to manage it.
Harness your expertise
See how QbDVision can help you leverage your team’s know-how to accelerate drug development.